Literature DB >> 1958024

Interference of monoclonal antibodies with proteolysis of antigens in cellular and in acellular systems.

F Manca1.   

Abstract

Monoclonal antibodies complexed with protein antigens can interfere with proteolytic degradation of the antigen. Depending on their fine specificity, they can "protect" well defined regions of the antigen. Because of steric hindrance between bound antibody and proteolytic enzyme, the protected region is larger than the minimal epitope recognized by the antibody binding site. The principle of limited proteolysis proves a valuable tool for the analysis of antigenic fragments and for epitope mapping. Since proteolysis of antigen also occurs in antigen presenting cells, degradation of antigen complexed with a monoclonal antibody (either taken up as an immunocomplex by Fc receptors, or taken up in complexed form with a surface immunoglobulin of a specific B cell) likely modulates the processing pattern of the antigen. This results in a different spectrum of peptides displayed by the antigen presenting cell and thus in different interactions with the antigen specific T cell repertoire. Modulation of T cell response and B cell response by using antigen complexed with different monoclonals is proposed as possible means of interfering with the fine specificity of the response.

Mesh:

Substances:

Year:  1991        PMID: 1958024

Source DB:  PubMed          Journal:  Ann Ist Super Sanita        ISSN: 0021-2571            Impact factor:   1.663


  6 in total

Review 1.  Antibody-mediated immunomodulation: a strategy to improve host responses against microbial antigens.

Authors:  L Jeannine Brady
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

2.  Monoclonal antibody-mediated modulation of the humoral immune response against mucosally applied Streptococcus mutans.

Authors:  L J Brady; M L van Tilburg; C E Alford; W P McArthur
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

3.  Redirecting the humoral immune response against Streptococcus mutans antigen P1 with monoclonal antibodies.

Authors:  Monika W Oli; Nikki Rhodin; William P McArthur; L Jeannine Brady
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

4.  Further characterization of immunomodulation by a monoclonal antibody against Streptococcus mutans antigen P1.

Authors:  Nikki R Rhodin; Marloes L J A Van Tilburg; Monika W Oli; William P McArthur; L Jeannine Brady
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

5.  Characterization of the Streptococcus mutans P1 epitope recognized by immunomodulatory monoclonal antibody 6-11A.

Authors:  Nikki R Rhodin; Jenny M Cutalo; Kenneth B Tomer; William P McArthur; L Jeannine Brady
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

6.  Beneficial immunomodulation by Streptococcus mutans anti-P1 monoclonal antibodies is Fc independent and correlates with increased exposure of a relevant target epitope.

Authors:  Rebekah A Robinette; Monika W Oli; William P McArthur; L Jeannine Brady
Journal:  J Immunol       Date:  2009-09-14       Impact factor: 5.422

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.